BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
about
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
description
clinical trial
@en
klinisch onderzoek
@nl
name
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
@en
type
label
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
@en
prefLabel
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
@en
P17
P1132
P1476
A Dose-Blind, Multicenter, Ext ...... g-Remitting Multiple Sclerosis
@en
P1813
ENDORSE
@en
P3098
NCT00835770
P580
2009-02-02T00:00:00Z
P582
2020-09-28T00:00:00Z